chitosan has been researched along with albendazole in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 13 (72.22) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, GP; Agrawal, S; Bhadra, S; Jain, SK; Pancholi, SS; Rai, G | 1 |
| Lamas, MC; Leonardi, D; Olivieri, AC | 1 |
| Li, P; Wang, AQ; Wang, FQ; Wei, Q; Zhang, JP | 2 |
| Bawudong, D; Chen, YL; Gu, JP; Liu, Y; Ren, WX; Wang, XQ; Xu, XD; Yu, Y; Zhang, JK; Zhang, XN | 1 |
| Alamdarnejad, G; Dadgar, M; Janmaleki, M; Kalaee, MR; Khakpour, M; Sharif, A; Taranejoo, S | 1 |
| Bolmaro, RE; García, A; Lamas, MC; Leonardi, D; Mamprin, ME; Piccirilli, GN; Salomón, CJ | 1 |
| García, A; Lamas, MC; Leonardi, D; Mamprin, ME; Olivieri, AC; Piccirilli, GN | 1 |
| Liang, W; Ma, X; Peng, XY; Sun, H; Wang, XC; Wu, XW; Zhang, SJ | 1 |
| Abulaihaiti, M; Aduwayi, N; Lv, HL; Peng, XY; Qiao, L; Wang, XC; Wang, YJ; Wu, XW; Zhang, HW | 1 |
| Jain, NK; Kesharwani, P; Mansuri, S; Tekade, RK | 1 |
| Chandrasekaran, R; Cheng, W; Hourigan, K; Janmaleki, M; Pachenari, M; Seyedpour, SM; Taranejoo, S | 1 |
| Codina, AV; Hinrichsen, LI; Lamas, MC; Leonardi, D; Priotti, J; Vasconi, MD | 1 |
| Choi, JS; Jang, WS; Kang, BS; Kim, JK; Kim, TH; Lee, JK; Lee, SE; Park, JS; Tunsirikongkon, A | 1 |
| Dobakhti, F; Faghihzadeh, S; Haniloo, A; Torabi, N | 1 |
| Arafa, MF; Ashour, DS; Eid, RK; El Maghraby, GM; Essa, EA | 1 |
| Abedi, M; Alizadeh, M; Darvishi, MM; Moazeni, M; Tamaddon, AM | 1 |
| Dai, Y; Geng, M; Ke, W; Li, F; Li, J; Li, K; Ma, Q; Qiu, Z; Wang, S; Wang, W | 1 |
18 other study(ies) available for chitosan and albendazole
| Article | Year |
|---|---|
Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.
Topics: Albendazole; Animals; Anthelmintics; Cecum; Chitosan; Colon; Drug Delivery Systems; Drug Stability; Drug Storage; Excipients; Ileum; In Vitro Techniques; Microscopy, Electron, Scanning; Microspheres; Particle Size; Rats; Spectrophotometry, Infrared | 2005 |
Multiresponse optimization of the properties of albendazole-chitosan microparticles.
Topics: Albendazole; Anthelmintics; Biocompatible Materials; Chitosan; Cross-Linking Reagents; Drug Carriers; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Particle Size; Sodium Hydroxide; Solubility; Spectrophotometry, Ultraviolet; Temperature | 2008 |
pH-sensitive magnetic alginate-chitosan beads for albendazole delivery.
Topics: Albendazole; Alginates; Antiprotozoal Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Magnetics; Magnetite Nanoparticles; Microscopy, Electron, Scanning; Microspheres; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2011 |
A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery.
Topics: Albendazole; Alginates; Anthelmintics; Biocompatible Materials; Chitosan; Data Interpretation, Statistical; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Magnetics; Microspheres; Nanoparticles; Polyethylene Glycols; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2010 |
Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Biocompatible Materials; Biological Availability; Chitosan; Drug Delivery Systems; Echinococcosis, Hepatic; Female; Intestinal Absorption; Liver; Male; Materials Testing; Mice; Mice, Nude; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley | 2013 |
Synthesis and characterization of thiolated carboxymethyl chitosan-graft-cyclodextrin nanoparticles as a drug delivery vehicle for albendazole.
Topics: Albendazole; Anthelmintics; Body Fluids; Chitosan; Coated Materials, Biocompatible; Cyclodextrins; Drug Compounding; Humans; Intestinal Secretions; Materials Testing; Nanoparticles; Pharmaceutical Vehicles; Sulfhydryl Compounds | 2013 |
Chitosan microparticles: influence of the gelation process on the release profile and oral bioavailability of albendazole, a class II compound.
Topics: Albendazole; Animals; Anthelmintics; Biological Availability; Chitosan; Drug Liberation; Male; Microscopy, Electron, Scanning; Particle Size; Powder Diffraction; Rats; Rats, Wistar; Sodium Dodecyl Sulfate; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2014 |
Spray drying formulation of albendazole microspheres by experimental design. In vitro-in vivo studies.
Topics: Administration, Oral; Albendazole; Animals; Area Under Curve; Biological Availability; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Drug Stability; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Microspheres; Pectins; Rats; Rats, Wistar | 2015 |
[Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice].
Topics: Albendazole; Animals; Chitosan; Echinococcosis; Echinococcus granulosus; Male; Mice; Microspheres | 2014 |
Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Chitosan; Disease Models, Animal; Drug Carriers; Echinococcosis; Echinococcosis, Hepatic; Echinococcus multilocularis; Histocytochemistry; Liver; Male; Mice; Microspheres; Plasma; Treatment Outcome | 2015 |
Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole.
Topics: Adhesives; Administration, Oral; Albendazole; Animals; Anthelmintics; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Dendrimers; Drug Carriers; Drug Delivery Systems; Freeze Drying; Half-Life; Male; Mucous Membrane; Rabbits; Rats; Rats, Sprague-Dawley; Tablets | 2016 |
Dual effect of F-actin targeted carrier combined with antimitotic drug on aggressive colorectal cancer cytoskeleton: Allying dissimilar cell cytoskeleton disrupting mechanisms.
Topics: Actins; Albendazole; Antimitotic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Colorectal Neoplasms; Cytoskeleton; Drug Carriers; Drug Liberation; Elasticity; Humans; Nanoparticles; Viscosity | 2016 |
Albendazole Microcrystal Formulations Based on Chitosan and Cellulose Derivatives: Physicochemical Characterization and In Vitro Parasiticidal Activity in Trichinella spiralis Adult Worms.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Biocompatible Materials; Biological Availability; Cellulose; Chitosan; Drug Delivery Systems; Solubility; Trichinella spiralis; Trichinellosis | 2017 |
Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Topics: Albendazole; Cell Survival; Chitosan; Drug Carriers; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes.
Topics: Albendazole; Animals; Anthelmintics; Chitosan; Echinococcosis; Echinococcus granulosus; Humans; Male; Mice; Mice, Inbred DBA; Microscopy, Electron, Transmission; Nanoparticles; Praziquantel; Sheep; Sheep Diseases; Suspensions | 2018 |
Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis.
Topics: Administration, Oral; Albendazole; Animals; Antiprotozoal Agents; Chitosan; Drug Carriers; Lipids; Nanostructures; Parasitic Sensitivity Tests; Particle Size; Surface Properties; Trichinella spiralis | 2020 |
Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Topics: Administration, Oral; Albendazole; Animals; Antiplatyhelmintic Agents; Chitosan; Drug Delivery Systems; Drug Evaluation, Preclinical; Echinococcosis; Echinococcus granulosus; Mice; Nanoparticles; Polyglycolic Acid | 2020 |
Topics: Albendazole; Animals; Chitosan; Echinococcosis; Echinococcus granulosus; Microspheres; Radiotherapy, Intensity-Modulated | 2021 |